Our technical organization orchestrates a balanced mix of internal and external capabilities also for manufacturing and supply chain. At our state-of-the-art manufacturing facility in Ireland, we manufacture commercial solid and semisolid dosage forms and handle high-potency drugs. Analytical testing and QP release are run on site, as is the management of the global supply chain that reaches patients all around the globe. Learn more about our journey to in-house product manufacturing and supply: https://lnkd.in/ekCtvEJp #manufacturing
Helsinn Group’s Post
More Relevant Posts
-
Next in line is the PL-Vision. It is an Inspection System for Pharma Leaflet Folding Machines. Pharma leaflet instruction sheets give product and usage information in different languages. In the process of production, sheets of different products tend to get mixed up. In order to avoid this mix up, our PL-Vision is used. This ensures that, the correct product information sheet goes with its corresponding product. #pharmaleaflet #inspectionsystem #pharmaleafletfoldingmachines #pharma #leaflet #leafletfoldingmachines
To view or add a comment, sign in
-
-
In the pharmaceutical industry, the balance in setting specifications is crucial for manufacturability. Initially, specifications should be moderately stringent, avoiding overly tight parameters that could lead to frequent batch failures and operational inefficiencies. This approach allows for a realistic assessment of the manufacturing process's capabilities and variability. As the process matures and a deeper understanding of the process control is established, specifications can and should be gradually tightened. This tightening reflects improved process understanding and control, ensuring consistent product quality. However, it's essential to approach this adjustment judiciously to maintain a balance between quality assurance and practical manufacturability. The goal is to ensure product quality and efficacy without imposing unnecessary constraints that could hinder production efficiency or escalate costs.
Enkrisi Quick Guide Setting Drug Specifications
https://www.youtube.com/
To view or add a comment, sign in
-
🚨 Don't let hose failures derail your pharma operations! Discover the critical points where failure can be catastrophic and how to prevent it. Stay ahead with our insights. 👉 Read more #Pharma #Manufacturing #ProcessEngineering #Liquidyne https://lnkd.in/gYvMFGD7
To view or add a comment, sign in
-
Enkrisi Quick Guide Setting Drug Specifications when Data is Scarce! Watch More Here! Gopi Vudathala Madison Peterson Rose Zhao #PharmaInnovation #RegulatoryStrategy #QualityByDesign #DrugDevelopmentInsights #CMCConsulting #BiotechBreakthroughs
In the pharmaceutical industry, the balance in setting specifications is crucial for manufacturability. Initially, specifications should be moderately stringent, avoiding overly tight parameters that could lead to frequent batch failures and operational inefficiencies. This approach allows for a realistic assessment of the manufacturing process's capabilities and variability. As the process matures and a deeper understanding of the process control is established, specifications can and should be gradually tightened. This tightening reflects improved process understanding and control, ensuring consistent product quality. However, it's essential to approach this adjustment judiciously to maintain a balance between quality assurance and practical manufacturability. The goal is to ensure product quality and efficacy without imposing unnecessary constraints that could hinder production efficiency or escalate costs.
Enkrisi Quick Guide Setting Drug Specifications
https://www.youtube.com/
To view or add a comment, sign in
-
Drug price transparency, reporting rules, formats, and timelines differ from state to state, and managing and meeting these requirements is a difficult, yet important, factor for #pharma manufacturers. Streamline the end-to-end state price transparency reporting process and consider a highly configurable application that enables you to comply with the evolving set of state regulations. Learn more: https://lnkd.in/e5mVCC6p #LifeSciences #Pricing #Compliance #ModelN
To view or add a comment, sign in
-
-
the tenth edition of "Quality Assurance of Pharmaceuticals : Acompendium of Guidelines and Related Materials" Volume 2 (Good Manufacturind Practices and Inspection) is now available for access through below link 👇👇
View Statistics
iris.who.int
To view or add a comment, sign in
-
Transparent reporting is the key!
Drug price transparency, reporting rules, formats, and timelines differ from state to state, and managing and meeting these requirements is a difficult, yet important, factor for #pharma manufacturers. Streamline the end-to-end state price transparency reporting process and consider a highly configurable application that enables you to comply with the evolving set of state regulations. Learn more: https://lnkd.in/e5mVCC6p #LifeSciences #Pricing #Compliance #ModelN
To view or add a comment, sign in
-
-
Rethinking the development of controlled release formulations and manufacturing processes Join this webinar to learn from Roquette and PharmaExcipients.com about to controlled release formulations in drug delivery and different manufacturing processes. Date & Time & Timezone: Apr 30, 2024 3:00 PM CET Registration: https://lnkd.in/ev6FRSDe
To view or add a comment, sign in
-
-
Would you rather spend 20 or 60 minutes on line clearance between batches? 🤔 When the goal is close-to-zero batch changeover time, the answer to that one is a no-brainer. An integral part of every single batch changeover, line clearance is there to prevent mislabeling or cross-contamination of finished pharmaceutical products 💉💊 The goal is to ensure that there are no components left from the previous batch when the next one is started. And it is NOT taken lightly: The SOPs and checklists guiding the line clearance process are rarely less than 50 pages long, detailing every single step of the process to ensure that nothing is missed. Clearing the line easily takes an hour of valuable production time – sometimes even more ⏱ But, given that humans with all their flaws are involved, no checklist is enough to be completely sure, despite the best effort of the operators. So why not boost both efficiency and accuracy by bringing in vision technology to support the work of the operators? Automating the line clearance process – or parts of it - adds an extra layer of security and reduces inspection time by as much as 75%. Want to know if your line clearance process can be automated? Get in touch or read more about our solution via the link below 👇 https://lnkd.in/gtzUBb4m #smartfactories #pharma #pharmaceuticalmanufacturing #bco #lineclearance
To view or add a comment, sign in
-
Combining visual #inspection and container closure integrity (#CCI) testing on a single machine platform is a strategic move towards achieving higher efficiency, reliability, and compliance in pharmaceutical manufacturing. In addition, machine platforms capable of handling various product types provide immense flexibility. This versatility allows to switch between different product lines without the need for multiple specialized machines, accommodating a wide range of production needs. These aspects have been given special consideration in the continuous development of the AIM5 platform - introduced by inspection expert Wolfram Schindler. #Syntegon #InspectionExperts
To view or add a comment, sign in